SuperworthIndivior Pharmaceuticals market cap INDV
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $4.1B
- Highest close in our data
- $5.1B
- Jun 2026
Indivior Pharmaceuticals is worth $4.1B at the close on Oct 23, 2026, at $34.47 a share.
That is up 30% over the last year.
Its highest close in our data was $5.1B in Jun 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $4.1B | $3.6B | $5.1B | −10% |
| 2025 | $4.5B | $1.1B | $4.5B | +167% |
| 2024 | $1.7B | $1B | $2.9B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Indivior Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| INDVIndivior Pharmaceuticals | $4.1B |
| ARQTArcutis Biotherapeutics | $3.9B |
| LQDALiquidia | $3.8B |
| OGNOrganon | $3.6B |
| NRIXNurix Therapeutics | $2.8B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ALKSAlkermes plc. | $7.3B |
| HRMYHarmony Biosciences | $2.1B |
| Peer median | $3.9B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Indivior Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.